Improved Anticancer Effect of Recombinant Protein izTRAIL Combined with Sorafenib and Peptide iRGD. [electronic resource]
Producer: 20190604ISSN:- 1422-0067
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Cell Survival -- drug effects
- Drug Resistance, Neoplasm -- drug effects
- Fibrosarcoma -- drug therapy
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Oligopeptides -- administration & dosage
- Recombinant Proteins -- administration & dosage
- Sorafenib -- administration & dosage
- TNF-Related Apoptosis-Inducing Ligand -- genetics
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.